and Huang, 1992) . The NMDA receptor can also be phosphorylated on its tyrosine residues via src (Yu et al., 1997) or the brain-derived neurotrophic factor (BDNF) receptor/tyrosine kinase TrkB (Suen et al., 1997 ; Figure  1 ), resulting in a change in channel open time and clustering. BDNF, interestingly, is present in dense core vesicles in substance P-expressing (TrkA-positive) C-fibers, and its receptor TrkB is present on dorsal horn neurons.
Posttranslational changes in the NMDA receptor, by increasing glutamate sensitivity, will boost the responses of spinal neurons to any subsequent glutamatergic input-the phenomenon of central sensitization. Central sensitization is responsible for several key elements of postinjury pain hypersensitivity, including the spread of abnormal sensitivity beyond the site of injury (secondary hyperalgesia) and the generation of pain by normally low threshold mechanoreceptors (allodynia) (Woolf, 1983) . The capacity of substance P to modify glutamate sensitivity may represent one of its prime actions, acting as a synaptic power-booster or turbocharger and thereby contributing to the initiation of central sensitization.
NK1 receptor antagonists reduce the development of central sensitization induced by electrical stimulation or chemical activation of C-fibers by irritants like mustard oil, capsaicin, or formalin. Substance P can transfer input from C-fibers to dorsal horn neurons by producing postsynaptic depolarizations. It is not essential, however, because of the multiple parallel transmitters/ receptors involved in C-fiber synaptic transmission. In shown, using neutralizing antisera and TrkA-Fc fusion tabotropic, ionotropic, and tyrosine kinase receptors that contribute to excitation as well as inhibitory receptors.
proteins, to be linked to inflammatory pain hypersensi-(B) In addition to generating inward currents in the postsynaptic tivity both by a direct action on the peripheral terminals neuron, C-fiber inputs initiate long-lasting alterations in the excitabilof nociceptors and by altering the phenotype of sensory ity as a result of the phosphorylation of the NMDA receptor.
neurons following retrograde transport of the NGF to the DRG. Acute inflammation results in an NGF-dependent ionotropic and metabotropic receptors on the postsynincrease in the numbers of cells expressing PPT-A aptic membrane (Figure 1 ). In addition to substance P, mRNA in the DRG. After inflammation, substance P bethere is an NMDA and mGluR component to the slow gins to be expressed in a subpopulation of DRG neurons synaptic current. NK1 antagonists reduce but do not with myelinated A-fibers that acquire some functional eliminate slow potentials evoked by C-fiber inputs. The properties normally associated only with C-fibers (Neu-C-fiber-evoked slow synaptic potential offers the oppormann et al., 1996)-the generation of action potential tunity for considerable temporal summation, and indeed after-discharge and induction of c-fos in dorsal horn such a use-dependent increase in C-fiber-evoked acneurons and production of progressive hypersensitivity tion potential discharge, termed windup by its discovin response to intermittent tactile stimulation. In keeping erer Lorne Mendell, does occur and is sensitive both to with the suggestion that the elevation in substance P NMDA and to NK1 antagonists. There is also complex siginduced by inflammation contributes to pain hypersensinaling on the presynaptic C-fiber terminal (see Figure 1) . tivity, increased NK1 receptor internalization on denSubstance P and Central Sensitization drites of cells in the dorsal horn in response to noxious While glutamate appears to be able to promote substimuli, and novel responses to previously innocuous stance P release via presynaptic NMDA autoreceptors stimuli, have been observed (Abbadie et al., 1997) , as (Liu et al., 1997) , substance P can potentiate the action of has upregulation of the NK1 receptor by dorsal horn glutamate on postsynaptic NMDA receptors, a complex neurons in inflammatory models (Krause et al., 1995) . reciprocal interaction, enhancing synaptic efficacy (Fig- In general, NK1 receptor antagonists reduce inflamure 1). PKC-mediate phosphorylation of the NMDA recepmatory pain hypersensitivity in various different animal tor partially relieves the voltage-dependent Mg 2ϩ block, models without affecting the normal responsiveness to which in turn enables glutamate to generate a greater noxious stimuli. Unfortunately, less success has been achieved in clinical trials. This is partly because some inward current through the NMDA ion channel (Chen of these drugs have nonspecific actions, particularly on a number of changes consistent with results using NK1 calcium channels, and because of limited brain peneand NK2 antagonists were observed-neurogenic intrance after systemic administration and variable bioflammation was significantly abolished, and mechanical availability after oral administration. In humans, NK1 ansensitivity was comparable to the wild-type animals tagonists have been reported to have no effect on (with the exception of very high intensity of stimulation migraine, little or no effect on dental postoperative pain, in the Basbaum PPT-A knockout, which showed deno effect on windup in human volunteers, and no effect creased sensitivity). Surprisingly, no changes in meon patients with osteoarthritis.
chanical hypersensitivity induced by inflammation were Measuring Pain seen in the NK1 and PPT-A knockout animals. Pain-related behavior can be tested in several different
In their PPT-A knockout, Basbaum and colleagues ways. The reaction to high intensity potentially tissuefound behavioral changes that they interpreted as indidamaging (noxious) stimuli can be investigated using cating an intensity-coding role for substance P. At low mechanical, thermal, or chemical stimuli applied to skin, intensity noxious stimulation, independent of modality, deep tissue, or viscera. Central sensitization in turn manthe mutants and wild types behaved the same; only at ifests as a hypersensitivity to peripheral stimuli following stimulation intensities producing moderate to severe the activation of C-fiber nociceptors. The formalin test, pain was the phenotype manifest, with no differences for example, has an immediate "early" phase that meaobserved at very high stimulation intensities. Although sures the direct response to the irritant (nociceptive this does not match findings in mice using NK1 and NK2 pain) and a "late" phase presenting after about 10 minantagonists (e.g., Seguin et al., 1995) , it is consistent utes that reflects changes in the excitability of neurons with the fact that greater stimulation intensities are in the spinal cord (central sensitization). The acetic acid required for substance P release than for glutamate rewrithing test, in contrast, is a test only of visceral nocilease from C-fibers. Where the data becomes more difceptive chemosensitivity. Inflammatory pain, which can ficult to evaluate is the analysis of central sensitizationbe tested by producing localized inflammation, has two both Zimmer (PPT-A) and Hunt (NK1), consistent with components-allodynia, the pain produced by normally the pharmacology, found a reduced second phase of innocuous stimuli, and hyperalgesia, an increased rethe formalin test (central sensitization), but this was norsponse to noxious stimuli. These take several hours to mal in the Basbaum PPT-A knockout. manifest.
Other inconsistencies between the null mutations Knocking out Substance P and the NK1 Receptor were also striking. The Zimmer PPT-A knockout showed Given the substantial information available on substance normal acetic acid writhing, whereas writhing was re-P pharmacology, certain expectations can be made about duced in the Basbaum PPT-A knockout. A reduced rethe likely phenotype of mice lacking either substance P sponse in the hotplate test at 52ЊC found in the Zimmer (Basbaum and Zimmer) or the NK1 receptor (Hunt): a PPT-A knockout was not observed at the same temperalack of neurogenic extravasation, minimal effect on ture for the Basbaum PPT-A knockout. The NK1 knockbaseline nociceptive sensitivity, reduced central sensitiout showed a reduced stress-induced analgesia, which zation, and diminished inflammatory hyperalgesia. De- was not observed in the Zimmer PPT-A knockout. spite the fact that ligand knockouts cannot be compared Although the phenotypes of the different knockouts directly with receptor knockouts, particularly since the clearly point to an involvement of substance P in pain, PPT-A knockouts eliminate both substance P and NKA, there is no simple explanation for the apparently inconwhich act on NK1 and NK2 receptors, respectively, some sistent behavioral responses of the different animals. commonality might be anticipated between the animals.
The knockout approach is susceptible to a number of All three knockouts appeared healthy, were fertile, and showed altered pain behavior. As Table 1 illustrates, problems related to the genetic background of the mice (Banbury Conference on Genetic Background in Mice, genetically and pharmacologically using protocols designed to evaluate opiate or nonsteroidal anti-inflamma-1997), the developmental actions of the deleted gene, tory type analgesics and not in studies where pain hyand redundancy of function and compensatory changes, persensitivity after inflammation is a prominent feature. as well as the sensitivity, specificity, and reproducibility However, despite the fact that available clinical trial data of the behavioral tests used to measure the phenotype are not encouraging, it may be premature to totally abanof the animals. All of these may contribute here. For don NK1 receptor antagonists for pain treatment. Since instance, there is a growing appreciation of the enor-C-fiber input to the CNS involves parallel transmitter mous strain differences in the response of mice to noxaction on multiple receptors, a polypharmacy approach ious stimuli and analgesic drugs. C57BL/6 mice are, might make more sense if one is targeting postsynaptic for example, very resistant to the analgesic actions of receptors. This could involve combinations of NK1, morphine. The Basbaum PPT-A knockout was created mGluR, and NMDA receptor antagonists together with from a different strain than the Zimmer PPT-A and the opioids to improve analgesic efficacy. Hunt NK1 knockouts; the mice have not been backIt is possible that substance P may be involved only crossed to a point where genetic stability is present, in severe pain, being released in the spinal cord by and as a consequence the diverse hybrid genetic backmassive amounts of tissue damage. Alternatively, subground of each animal raises the possibility that differstance P may play a nonessential role in the pathophysiences in modifier genes may alter the phenotype indeology of pain, such that eliminating its action does not pendently of the mutation. It is likely that the differences eliminate pain. Rather than signaling the presence or in strains are responsible for some of the inconsistencies absence of noxious stimuli, it is possible that substance in the behavioral tests-there are larger differences be-P, acting in parallel rather than serial synaptic informatween the reaction times to a standard nociceptive test tion transfer, contributes to synaptic gain more than (hotplate at 52ЊC) between Hunt wild-type mice and Zimpain and that its action is more one of modulation than mer and Basbaum wild types than with the gene deletransmission. tions. The Basbaum wild-type mice generated Ͼ30 abdominal stretches with acetic acid, whereas Zimmer only a proportion of receptors are likely to be blocked at effective doses. A further issue is the possibility that Liu, H., Mantyh, P.W., and Basbaum, A.I. (1997) . Nature 386, [721] [722] [723] [724] the knockouts alter aspects of higher central processing Mantyh, P.W., DeMaster, E., Malhotra, A., Ghilardi, J.R., Rogers, in a way that may modify pain reactions. This appears S.D., Mantyh, C.R., Liu, H., Basbaum, A.I., Vigna, S.R., Maggio, J.E., to be true for the NK1 knockout, where an action on and Simone, D.A. (1995) . Science 268, 1629 Science 268, -1632 stress and aggression was detected.
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